Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Diabetes 56:88-95, 2007
DOI: 10.2337/db06-0948
© 2007 by the American Diabetes Association
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Moibi, J. A.
Right arrow Articles by Leahy, J. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Moibi, J. A.
Right arrow Articles by Leahy, J. L.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Peroxisome Proliferator–Activated Receptor-{gamma} Regulates Expression of PDX-1 and NKX6.1 in INS-1 Cells

Jacob A. Moibi1, Dhananjay Gupta2, Thomas L. Jetton2, Mina Peshavaria2, Ronak Desai2, and Jack L. Leahy2

1 Cross Cancer Institute, University of Alberta, Edmonton, Alberta, Canada
2 Division of Endocrinology, Diabetes, and Metabolism, Department of Medicine, University of Vermont, Burlington, Vermont

Address correspondence and reprint requests to Dr. Jack Leahy, University of Vermont College of Medicine, Given Bldg. C331, Burlington, VT 05405. E-mail: jleahy{at}uvm.edu

Abbreviations: Pdx, pancreatic duodenal homeobox; PPAR, peroxisome proliferator–activated receptor; Px, pancreatectomy; RNAi, RNA interference; siRNA, small interfering RNA; UCP, uncoupling protein

In the 60% pancreatectomy (Px) rat model of ß-cell adaptation, normoglycemia is maintained by an initial week of ß-cell hyperplasia that ceases and is followed by enhanced ß-cell function. It is unknown how this complex series of events is regulated. We studied isolated islets and pancreas sections from 14-day post-Px versus sham-operated rats and observed a doubling of ß-cell nuclear peroxisome proliferator–activated receptor (PPAR)-{gamma} protein, along with a 2-fold increase in nuclear pancreatic duodenal homeobox (Pdx)-1 protein and a 1.4-fold increase in ß-cell nuclear Nkx6.1 immunostaining. As PPAR-{gamma} activation is known to both lower proliferation and have prodifferentiation effects in many tissues, we studied PPAR-{gamma} actions in INS-1 cells. A 3-day incubation with the PPAR-{gamma} agonist troglitazone reduced proliferation and increased Pdx-1 and Nkx6.1 immunostaining, along with glucokinase and GLUT2. Also, a 75% knockdown of PPAR-{gamma} using RNA interference lowered the mRNA levels of Pdx-1, glucokinase, GLUT2, and proinsulin II by more than half. Our results show a dual effect of PPAR-{gamma} in INS-1 cells: to curtail proliferation and promote maturation, the latter via enhanced expression of Pdx-1 and Nkx6.1. Additional studies are needed to determine whether there is a regulatory role for PPAR-{gamma} signaling in the ß-cell adaptation following a 60% Px in rats.


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2007 by the American Diabetes Association.